NDC product
Ifosfamide
NDC 21586-211 · SteriMax Inc.
Key facts
| Product NDC | 21586-211 |
|---|---|
| Proprietary name | Ifosfamide |
| Nonproprietary name | Ifosfamide for Injection |
| Substances | IFOSFAMIDE |
| Dosage form | POWDER, FOR SOLUTION |
| Route | INTRAVENOUS |
| Labeler | SteriMax Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE |
| Pharmacologic classes | Alkylating Activity [MoA], Alkylating Drug [EPC] |
| Marketing start | Sep 4, 2026 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: